NCT04964024View on ClinicalTrials.gov

SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes

CompletedOBSERVATIONAL
Enrollment

1,293

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

May 15, 2022

Study Completion Date

May 15, 2022

Conditions
COVID-19 Infection
Interventions
DIAGNOSTIC_TEST

SARS-CoV-2 antibodies

Analysis of the results of the serological response to COVID-19 and/or Vaccine

Trial Locations (1)

54500

CHRU de Nancy, Université de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER